PRNP and X-linked retinal dysplasia: The ability of EVs injected into the blood to evoke functional effects in the brain across the blood–brain barrier (BBB) makes these an attractive therapeutic candidate for delivering pharmacological treatments capable of targeting PrPC directly to ameliorate pathogenesis of PrD.